Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BioremBIRMF 86 EBITDA Margin % is 18.04% as of Jun. 2026, which is 78% above its 10-year median of 10.11. GuruFocus rates BIRMF with a GF Score™ of 86/100 and a GF Value™ of $2.32 (Modestly Overvalued). The stock has 4 warning signs investors should review. Among 3,038 Industrial Products companies, Biorem ranks better than 77.91% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Biorem's EBITDA for the
three
months ended in Jun. 2026 was $2.02 Mil. Biorem's Revenue for the
three
months ended in Jun. 2026 was $11.18 Mil. Therefore, Biorem's EBITDA margin for the quarter that ended in Jun. 2026 was 18.04%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Biorem EBITDA Margin % Related Terms
Biorem EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Biorem's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BIRMF vs VLTO, ZWS, CECO: EBITDA Margin % Comparison
For the Pollution & Treatment Controls subindustry, Biorem's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Biorem EBITDA Margin % vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, Biorem's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Biorem's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biorem (BIRMF) has a EBITDA Margin % of 18.04% as of Jun. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Biorem and its competitors. This is 78% above median its historical median of 10.11. According to the industry distribution chart, Biorem ranks #671 out of 3038 companies in the Industrial Products industry, placing it in the top 22.1%.
Is Biorem's EBITDA Margin % too high?
Biorem's current EBITDA Margin % of 18.04% is 78% above median its 10-year median of 10.11. The Industrial Products industry median EBITDA Margin % is 9.48. Biorem's value of 18.04% is 90.4% above this industry median. Based on the distribution chart, Biorem ranks #671 out of 3038 companies in the Industrial Products industry, which is in the top quartile — a strong position relative to peers. Overall, Biorem has a GF Score™ of 86/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Biorem's EBITDA Margin % compare to VLTO and ZWS?
According to the Industrial Products industry distribution chart, Biorem ranks #671 out of 3038 companies for EBITDA Margin %. This places Biorem in the top 22% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 9.48. Biorem's value of 18.04% is 90.4% above this benchmark. While the company's 10-year median is 10.11 vs. the industry median of 9.48, Biorem has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for an Industrial Products company?
The median EBITDA Margin % among Industrial Products companies is 9.48, based on 3,038 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Biorem's current EBITDA Margin % of 18.04% is 90.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Biorem and its competitors. For the Industrial Products industry, the median EBITDA Margin % is 9.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Biorem's current EBITDA Margin % is 18.04%, which is 78% above median its own 10-year median of 10.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biorem stock overvalued right now?
Based on GuruFocus' analysis, Biorem (BIRMF) is currently considered Modestly Overvalued. The stock's GF Value™ is $2.32, compared to a current price of $2.78 — trading 19.8% above its estimated fair value. The current EBITDA Margin % is 18.04%, which is 78% above median its 10-year median of 10.11 and 90.4% above the Industrial Products industry median of 9.48. Biorem's overall GF Score™ is 86/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Biorem (BIRMF), the current EBITDA Margin % is 18.04% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Biorem (BIRMF) Overvalued in 2026?
Based on GuruFocus' analysis, Biorem stock appears to be overvalued.
The current stock price of $2.78 is trading 19.8% above its estimated GF Value™ of $2.32.
GuruFocus considers Biorem to be Modestly Overvalued.
Key valuation signals for BIRMF:
EBITDA Margin %: 18.04% (78% above median its 10-year median of 10.11)
GF Value™: $2.32 vs. price of $2.78 (19.8% above fair value)
Industry Position: 90.4% above the Industrial Products median (#671 of 3038)
No single metric tells the full story. See the BIRMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Biorem Inc is an environmental biotechnology company. It is involved in the manufacturing of a comprehensive line of high efficiency air pollution control systems that are used to eliminate odorous and harmful contaminants. The company's products include Biofilters, Biogas Solutions, Multi-Stage Systems, Biotrickling filters, and services such as Media Sampling and Analysis, Biological processes and testing, Media replacements and Spare parts, and other related services. The company derives revenues from the sale of standard products, construction projects for specialized products, and services for repairs and maintenance. The group has a business presence in Canada, the United States, China and others, of which key revenue is derived from the United States.
86GF Score
Get the complete analysis for BIRMF
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BIRMF has been successfully added to your 
